This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

proofread

The link between defective autophagy and pancreatitis could point to new treatments

Autophagy in pancreatitis
(A) Representative H&E staining image of a mouse pancreas. The black arrow denotes the acinar cells and the white arrow denotes the islet. (B) Representative image of electron microscopy analysis of mouse pancreatic acinar cells. The white dotted line and the arrow denote the apical membrane. The black dotted line and the arrow denote the basal lateral membrane. ER, endoplasmic reticulum; M, mitochondria; N, nucleus; ZG, zymogen granule. Credit: Wen-Xing Ding, Xiaowen Ma, Sydney Kim, Shaogui Wang and Hong-Min Ni.

Researchers are exploring a new potential avenue for pancreatitis treatment: autophagy, a cellular recycling process. Autophagy helps maintain healthy pancreatic acinar cells by removing damaged organelles like mitochondria and the endoplasmic reticulum (ER).

A new review published in eGastroenterology highlights the link between defective and pancreatitis. Impaired autophagy contributes to pancreatitis by allowing damaged organelles to accumulate within acinar cells. This accumulation disrupts cellular function and can ultimately lead to .

"Autophagy plays a vital role in keeping pancreatic acinar cells healthy," explains Dr. Wen-Xing Ding, lead author of the study. "When autophagy is defective, damaged organelles build up, stressing the cells and potentially contributing to pancreatitis."

The review also explores the role of mitochondrial dysfunction and lysosomal dysfunction in pancreatitis. Mitochondria are the cell's powerhouses, and lysosomes are the compartments responsible for breaking down cellular waste. Both mitochondrial damage and impaired lysosomal function are observed in pancreatitis, further hindering the cell's ability to clear out damaged components.

The research team identified several within the autophagy pathway. VMP1, a protein involved in both autophagy and ER-phagy (removal of damaged ER), is downregulated in pancreatitis. TFEB, a master regulator of lysosomal biogenesis and autophagy, is also decreased. Additionally, disrupts autophagy by increasing ATG4B, a protease that regulates LC3-II, a key autophagy protein.

Autophagy in pancreatitis
A scheme for the autophagy machinery in mammalian cells. Credit: Wen-Xing Ding, Xiaowen Ma, Sydney Kim, Shaogui Wang and Hong-Min Ni.

"Animal studies suggest that manipulating these proteins can influence the severity of pancreatitis," Dr. Ding says. "Upregulating VMP1 or TFEB, or downregulating ATG4B, enhances autophagy and protects against pancreatitis."

While further research is needed, targeting autophagy may offer a novel therapeutic approach for pancreatitis. Future studies will focus on the specific role of autophagy receptors in targeting damaged organelles during pancreatitis and the potential for manipulating autophagy to treat the disease in humans.

More information: Wen-Xing Ding et al, Recent insights about autophagy in pancreatitis, eGastroenterology (2024). DOI: 10.1136/egastro-2023-100057

Provided by First Hospital of Jilin University
Citation: The link between defective autophagy and pancreatitis could point to new treatments (2024, May 24) retrieved 24 June 2024 from https://medicalxpress.com/news/2024-05-link-defective-autophagy-pancreatitis-treatments.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study sheds light on relationship between mitochondrial calcium dynamics and autophagy

57 shares

Feedback to editors